This inventor holds 1 USPTO granted patent. Top assignee: Biomeme Incorporated. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations by Benjamin Charles Schneller
Introduction
Benjamin Charles Schneller is an accomplished inventor based in Cary, NC (US). He has made significant contributions to the field of medical diagnostics, particularly in the characterization of infections. His innovative work has the potential to improve the accuracy and efficiency of infection detection and management.
Latest Patents
Schneller holds a patent for "Methods for characterizing infections and methods for developing tests for the same." This patent outlines methods for developing tests to determine the presence or absence of infections, including those related to sepsis. It also describes techniques for identifying the etiology of infections and differentiating between infectious diseases and non-infectious disorders, such as systemic inflammatory response syndrome (SIRS). The patent further includes systems and computer-implemented methods for developing and utilizing these tests.
Career Highlights
Schneller is currently associated with Biomeme Incorporated, where he applies his expertise in medical diagnostics. His work at Biomeme focuses on advancing technologies that enhance the detection and understanding of infections. With a patent portfolio that includes 1 patent, Schneller continues to contribute to the field of healthcare innovation.
Collaborations
Schneller collaborates with notable colleagues, including Christopher Woods and Ricardo Henao Giraldo. Their combined efforts aim to push the boundaries of infection diagnostics and improve patient outcomes.
Conclusion
Benjamin Charles Schneller's innovative work in infection characterization and testing methods exemplifies the impact of dedicated inventors in the medical field. His contributions are paving the way for advancements in diagnostic technologies that can significantly benefit healthcare practices.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile